Increased risk of psoriasiform diseases with anti-TNF agents

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1708卷 / 1期
关键词：
D O I：
10.1007/s40278-018-48102-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [41] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [42] TNF and anti-TNF agents in Behçet's disease
    KT Calamia
    Arthritis Res Ther, 5
  • [43] The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: A review
    Grinblat, Beni
    Scheinberg, Morton
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (04) : 251 - 255
  • [44] Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis
    Seneschal, Julien
    Lepreux, Sebastian
    Bouyssou-Gauthier, Marie-Laure
    Heliot-Hosten, Isabelle
    Economu, Andra
    Dehais, Joel
    Schaeverbeke, Thierry
    Taieb, Alain
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (01) : 77 - 80
  • [45] Anti-TNF Agents Induce Alternative Macrophages
    Degboe, Yannick
    Rauwel, Benjamin
    Baron, Michel
    Boyer, Jean Frederic
    Cantagrel, Alain
    Constantin, Arnaud
    Davignon, Jean-Luc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [46] An Update on Anti-TNF Agents in Ulcerative Colitis
    Samaan, Mark A.
    Bagi, Preet
    Vande Casteele, Niels
    D'Haens, Geert R.
    Levesque, Barrett G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 479 - +
  • [47] Comparison of causes of drug discontinuation between anti-TNF agents and 'non-anti-TNF biologic agents' in anti-TNF inadequate responder RA patients
    Du Pan, S. Martin
    Neto, D.
    Zufferey, P.
    Ciurea, A.
    Ziswiler, H. R.
    Gabay, C.
    Finckh, A.
    SWISS MEDICAL WEEKLY, 2013, 143 : 5S - 5S
  • [48] Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications
    Levy, Roger A.
    Guzman, Renato
    Castaneda-Hernandez, Gilberto
    Martinez-Vazquez, Manuel
    Damian, Guilherme
    Cara, Carlos
    IMMUNOTHERAPY, 2016, 8 (12) : 1427 - 1436
  • [49] Anti-TNFα therapy in inflammatory lung diseases
    Malaviya, Rama
    Laskin, Jeffrey D.
    Laskin, Debra L.
    PHARMACOLOGY & THERAPEUTICS, 2017, 180 : 90 - 98
  • [50] Do anti-TNF agents and combination treatment increase postoperative complication risk?
    Yonal, Oya
    Hatemi, Gulen
    Hamzaoglu, Hulya Over
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2012, 23 : 25 - 29
12345